Literature DB >> 6771928

Diflubenzuron: intestinal absorption and metabolism in the rat.

A G Willems, H Overmars, P Scherpenisse, N De Lange, L C Post.   

Abstract

1. The metabolic fate of the insecticide diflubenzuron was investigated in the rat with radioactively labelled forms of the compound. 2. Intestinal absorption, measured as the sum of urinary and biliary excretion, diminished greatly with increasing dose, from about 50% at 4 mg/kg to about 4% at 900 mg/kg. 3. Excretion was almost complete at 72 h after dosing. At that time up to 4% of a dose was recovered from the carcasses of the rats. No detectable excretion of radioactive CO2 occurred (less than 0.5% of dose). 4. The metabolic pattern in urine and bile was investigated with diflubenzuron labelled with both 3H and 14C. No unchanged compound was detected. About 80% of the metabolites appeared to have the basic diflubenzuron structure intact. Three of these, hydroxylated at either aromatic ring, were identified; they were largely excreted as conjugates in the bile. The remainder, also largely excreted in the bile, constituted very polar material. About 20% of the diflubenzuron underwent scission of the ureido bridge. One scission product, 2,6-difluorobenzoic acid, was largely excreted as such in the urine. Its counterpart, 4-chlorophenylurea, was not present in urine or bile in appreciable quantity; nor was 4-chloroaniline detected.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6771928     DOI: 10.3109/00498258009033736

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  2 in total

1.  Role of metabolism in effects of diflubenzuron on growth of B16 melanomas in mice.

Authors:  V K Jenkins; R R Perry; A E Ahmed; K Ives
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

2.  Effects of diflubenzuron on growth of malignant melanoma and skin carcinoma tumors in mice.

Authors:  V K Jenkins; R T Mayer; R R Perry
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.